Raja Rajalingam

7PUBLICATIONS
18CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Transplantation immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 28, 2026
Expanded Allelic Diversity of Non-Classical HLA Class I and MIC Loci Identified Using Full-Gene Hybrid Capture-Based Next-Generation Sequencing.

|May 06, 2025
Efficacy of Steroid Pulse to Treat Borderline T-Cell Mediated Rejection on Protocol Kidney Allograft Biopsy.

Georgia Kirn, Sindhu Chandran, Raja Rajalingam

|Oct 14, 2022
KIR-HLA gene diversities and susceptibility to lung cancer.

Marjan Hematian Larki, Elham Ashouri, Shaghik Barani

|Dec 01, 2021
Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.

Vasishta S Tatapudi, Dessislava Kopchaliiska, Gilberto J da Gente

|Jul 17, 2021
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma.

Haibo Sun, Thomas G Martin, John Marra

|Dec 06, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.

Zinal S Chheda, Gary Kohanbash, Kaori Okada

Pageof 2

Frequent Collaborators

1 joint publications

Gary Kohanbash

1 joint publications

Naznin Jahan

1 joint publications

Diego A Carrera

1 joint publications

Shruti Shrivastav